Nuveen
MLAB icon

Nuveen’s Mesa Laboratories MLAB Stock Holding History

Nuveen’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
13,896
+3,757
+37% +$378K ﹤0.01% 2772
2026
Q1 		$896K Buy
10,139
+61
+0.6% +$5.26K ﹤0.01% 2627
2025
Q4 		$791K Hold
10,078
– – ﹤0.01% 2714
2025
Q3 		$675K Sell
10,078
-5,846
-37% -$421K ﹤0.01% 2791
2025
Q2 		$1.5M Sell
15,924
-3,500
-18% -$384K ﹤0.01% 2425
2025
Q1 		$2.3M Buy
19,424
+6,318
+48% +$861K ﹤0.01% 2285
2024
Q4 		$1.73M Hold
13,106
– – ﹤0.01% 2447
2024
Q3 		$1.7M Hold
13,106
– – ﹤0.01% 2498
2024
Q2 		$1.14M Hold
13,106
– – ﹤0.01% 2671
2024
Q1 		$1.44M Hold
13,106
– – ﹤0.01% 2548
2023
Q4 		$1.37M Buy
13,106
+120
+0.9% +$11.7K ﹤0.01% 2588
2023
Q3 		$1.36M Sell
12,986
-122
-0.9% -$15.6K ﹤0.01% 2449
2023
Q2 		$1.68M Sell
13,108
-6,194
-32% -$944K ﹤0.01% 2426
2023
Q1 		$3.37M Buy
19,302
+271
+1% +$48.6K ﹤0.01% 2107
2022
Q4 		$3.16M Sell
19,031
-223
-1% -$34.9K ﹤0.01% 2170
2022
Q3 		$2.71M Sell
19,254
-454
-2% -$82.8K ﹤0.01% 2234
2022
Q2 		$4.02M Buy
19,708
+2,166
+12% +$474K ﹤0.01% 2093
2022
Q1 		$4.66M Sell
17,542
-650
-4% -$177K ﹤0.01% 2094
2021
Q4 		$5.78M Sell
18,192
-1,237
-6% -$388K ﹤0.01% 2034
2021
Q3 		$6.09M Sell
19,429
-953
-5% -$271K ﹤0.01% 2102
2021
Q2 		$5.53M Buy
20,382
+3,216
+19% +$816K ﹤0.01% 2193
2021
Q1 		$4.18M Sell
17,166
-307
-2% -$84.5K ﹤0.01% 2249
2020
Q4 		$5.01M Buy
17,473
+551
+3% +$152K ﹤0.01% 2077
2020
Q3 		$4.31M Buy
16,922
+1,267
+8% +$301K ﹤0.01% 1999
2020
Q2 		$3.39M Buy
15,655
+360
+2% +$83K ﹤0.01% 2099
2020
Q1 		$3.46M Buy
15,295
+7,299
+91% +$1.8M ﹤0.01% 1907
2019
Q4 		$1.99M Sell
7,996
-6,149
-43% -$1.44M ﹤0.01% 2421
2019
Q3 		$3.36M Buy
14,145
+577
+4% +$133K ﹤0.01% 2156
2019
Q2 		$3.32M Buy
+13,568
New +$3.16M ﹤0.01% 2202

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen's MLAB Position: Q2 2026 in Review

Nuveen increased its Mesa Laboratories (MLAB) stake by 37% in Q2 2026, buying an estimated $378K and bringing the position to 13,896 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

Nuveen first reported a position in MLAB in Q2 2019 and has held it in 29 quarters since. The position peaked at $6.09M in Q3 2021. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Nuveen held 13,896 shares of Mesa Laboratories worth $1.38M as of Q2 2026.
  • Nuveen bought 3,757 Mesa Laboratories shares in Q2 2026, an estimated $378K.
  • Mesa Laboratories made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2772 holding.
  • Nuveen first reported a position in Mesa Laboratories in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Mesa Laboratories position peaked at $6.09M in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.